NASH NASH NASH NASH NASH NASH...
Post# of 148286
NASH has to be up with the main priorities. The trial is only half a year and even a decent result will open up the floodgates to funding possibilities because the world is waiting on a therapy for the indication.
It seems like a no-brainer that we need to get the trial enrolled ASAP, which means we need more than just the one site in Miami.